NL-OMON44332
Completed
N/A
BIOmarkers for cogNitive Impairment due to Cerebral Amyloid Angiopathy (BIONIC) - BIONIC
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Radboud Universitair Medisch Centrum
- Enrollment
- 375
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Important notice: we plan to use left\-over body fluids (CSF, serum) from neurological controls and dementia patients. We will not actively recruit new patients in these categories.
- •However, we plan to recruit a maximum of 40 new CAA patients to this study; therefore the inclusion and exclusion criteria listed below only apply to this category of patients. The other patient groups are only listed in this ABR form (see above) for the sake of completeness.;Inclusion criteria for CAA patients:
- •In order to be eligible to participate, a subject must meet the following criteria:
- •\- Fulfilment of the modified Boston criteria for CAA (Linn, 2010; Smith, 2003\)
- •\- Subjects are mentally competent to take a decision on participation.
- •\- Written informed consent
- •\- Age \>55 years
Exclusion Criteria
- •Important notice: we plan to use left\-over body fluids (CSF, serum) from neurological controls and dementia patients. We will not actively recruit new patients in these categories.
- •However, we plan to recruit a maximum of 40 new CAA patients to this study; therefore the inclusion and exclusion criteria listed below only apply to this category of patients. The other patient groups are only listed for the sake of completeness.;Exclusion criteria for CAA patients:
- •\- Presence of blood coagulopathy, established by medical history
- •\- History of neurological or psychiatric disease
- •\- Allergy to local anesthetic agents
- •\- Contra\-indication for lumbar puncture: medical history of compression of spinal cord, spinal surgery, skin infection, developmental abnormalities in lower spine
- •\- Subjects who are currently participating in another study or have participated in a clinical study within the previous 30 days, based on their own report
- •\- Subjects with a history of drug or alcohol abuse
- •\- Subjects who are part of the study staff personnel or family members of the study staff personnel
- •\- Clinical (or previous MRI) evidence of structural (space occupying) cerebral abnormalities that are not compatible with the performance of a lumbar puncture , including malignancies, abscesses or obstructive hydrocephalus.;Contraindications for MRI:
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Markers for neurocognitive impairment in congenitally CMV infected infants: MARVELYS studycongenital cytomegalovirus infection100407921004743810007951NL-OMON43495Academisch Medisch Centrum100
Not Yet Recruiting
N/A
The effect of hearing loss in the perception of musical emotioNot ApplicableKCT0008341Hallym University100
Not Yet Recruiting
N/A
Multiple neurophysiologic biomarkers evaluated the pulmonary function of ALS.amyotrophic lateral sclerosis(ALS)JPRN-UMIN000042222ara Medical University20
Recruiting
N/A
A Study to find markers in blood and cerebrospinal fluid to help diagnose tuberculosis of the braiHealth Condition 1: A179- Tuberculosis of nervous system, unspecifiedCTRI/2020/04/024423niversity Hospital Frankfurt
Completed
N/A
Biomarker Development for Postoperative Cognitive Impairment in the ElderlyNL-OMON44903Charite Berlijn500